ACC : Disclosure of other UPSI/material event

No. ACC/Sec/SE/22/079

December 3, 2022

National Stock Exchange

BSE Limited

of India Limited

Corporate Relations

Exchange Plaza, 5th Floor

Department

Plot No.C/1, G Block,

P.J. Towers, Dalal Street

Bandra Kurla Complex,

Mumbai 400 001

Bandra (East), Mumbai 400 051

Scrip Code: 500410

Scrip Code: ACC

Dear Sir/ Madam,

Annexure

Particulars

Details

Reason

for

change

viz.

Appointment of Mr. Ajay Kapur (DIN:

appointment,

resignation,

03096416) as a Non-Independent

removal, death or otherwise

Director and Chief Executive Officer of

the Company.

Date of appointment & term of

from December 3, 2022.

appointment

Retirement by rotation

Brief profile

Mr. Kapur is an economics graduate

from St. Xavier's University, Mumbai

and an MBA from K. J. Somaiya

Institute of Management.

He has also attended the Advanced

Management

Programme

at

The

Wharton School of the University of

Pennsylvania.

Mr.

Kapur

has

been

actively involved in various industry

forums including Cll, FICCI and

ASSOCHAM.

Mr. Ajay Kapur has 25+ years of

experience in the cement and

construction, power and heavy metals

sector. He joined Ambuja Cement in

1993 as an Executive Assistant to the

then Managing

Director.

He

held

various strategic positions over the last

2 decades and from 2014 to 2019, he

served as the CEO and Managing

Director of the Ambuja.

Prior to joining the Adani Group in June

2022, Mr. Ajay Kapur was CEO-

Aluminium and Power and MD-

Commercial at Vedanta Ltd.

Disclosure

of

Relationship

Mr. Kapur is not related to any Director

between Directors (in case of

of the Company.

appointment as a Director)

Particulars

Details

Reason

for

change

viz.

Appointment of Ms. Ameera Shah (DIN:

appointment,

resignation,

00208095),

as Woman

Independent

removal, death or otherwise

Director of the Company.

Date of appointment & term of

December 3, 2022, for a period of 3

appointment

years i.e. upto December 2, 2025

Brief profile

Ms. Ameera Shah is the Promoter &

Managing

Director of

Metropolis

Healthcare Ltd. For the last 20 years,

Ms. Shah has focused on delivering

sustained growth, built and led

corporate functions, including finance,

strategy, business process optimization,

innovation, investor relations etc.

An eminent industry spokesperson, she

has been featured as a speaker in

various

National and

International

forums, industry events and conclaves

organized by IIM, Harvard Business

School, TedX, CII, FICCI, Twitter

amongst others. She has also been

elected the Secretary of the IAPL

(Indian

Association of

Pathology

Laboratories) and has served as the

Chairperson of the 'FICCI Health

services Western Subgroup' that drives

policy decisions at the Center.

Ms. Shah has served as an Independent

Director on the board of reputed Indian

companies (Kaya, Shoppers Stop). She

is an Independent Director on the board

of Torrent Pharma and is also an

advisor to Baylor College of Medicine.

She is also on the global advisory board

of AXA, a Paris headquartered company

with 700 Billion $ under asset

management.

Disclosure

of

Relationship

Ms. Shah is not related to any Director

between Directors (in case of

of the Company

appointment as a Director)